09.18.26 -- When To Trust And When To Verify AI-Enabled Validation Systems

Discover how safety‑by‑design principles in chemical synthesis help control exothermic reactions, reduce scale‑up risk, and enable safer, more reliable manufacturing of complex drug substances.

Cartridge drug delivery demands strict controls to guarantee dose accuracy. Early development and testing eliminate variability, prevent defects, and protect patient safety.

The speed of drug development depends as much on equipment choices as scientific expertise. See how flexible, integrated tools reduce delays, improve data quality, and enable faster decisions.

Shift from basic compliance to a strategic GxP culture. Explore how intentional, role-specific training and leadership support reduce risks and improve business outcomes in this video.

Uncover how early device strategy and integrated planning can streamline development, reduce risk, and accelerate your path to commercial success.

Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

Remote Raman spectroscopy enables accurate material identification at long distances without complex focusing. Learn how pathlength, sample properties, and substrate choice impact signal quality.

Domestic pharmaceutical manufacturing strengthens supply chain resilience, simplifies distribution, speeds market response, and reduces risk by aligning production with key markets.

Examine how transitioning to cloud-native architectures drives business agility in biopharma, reducing infrastructure costs, minimizing downtime, and accelerating time to market for novel therapies.

Hear from Hannah McLachlan on what crystallization screening delivers for peptide therapeutics — more stable material, higher purity, and a molecule clients can store without specialist infrastructure.

A framework for evaluating fill/finish CDMO RFPs beyond price and capacity, helping procurement teams uncover hidden costs, assess risk, and select partners built for scale.

Delve into how integrating inline buffer formulation with chromatography reduces buffer waste by 50% and delivers a 710% ROI, transforming downstream efficiency and sustainability.

Stop optimizing supplier selection for cost alone. This playbook gives pharma executives a cross-functional framework for selecting CDMOs and API manufacturers that won't fail you later.

Combine innovative technologies to enable precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.

Stop treating contamination control as a late-stage detail. Take a look at how making early, intentional design choices prevents startup delays and ensures your new cleanroom is ready for inspection.

Review five key factors that drive a seamless technology transfer, highlighting how a culture of technical expertise, customer focus, and operational flexibility is crucial to success.

Discover four essential bioprocess scale-up criteria and how each balances hydrodynamics, shear, and mass transfer across manufacturing scales.